Pacific biosciences of california stock.

Find the latest Pacific Biosciences of California, Inc. (PACB) stock quote, history, news and other vital information to help you with your stock trading and investing.You can hold this stock in a SIPP, ISA, JISA and Trading Account. Market Cap. $2.030bn. Div. Yield. -. Volume. 6,012,760. Open Price. $8.49. Prev. Close. $8.58.Pacific Biosciences of California Inc. PACB (U.S.: Nasdaq) Pacific Biosciences of California Inc. View All companies. AT CLOSE 1:00 PM EST 11/24/23. $8.55 USD. Stock Lists Headlines About Pacific Biosciences of California Stock Price, News & Analysis (NASDAQ:PACB) $8.55 +0.19 …

Find the latest Pacific Biosciences of California, Inc. (PACB) stock quote, history, news and other vital information to help you with your stock trading and investing.Pacific Biosciences of California, Inc. Q4 Loss Increases, but beats estimates. (RTTNews) - Pacific Biosciences of California, Inc. (PACB) released Loss for its fourth quarter that increased from ...Complete Pacific Biosciences of California Inc. stock information by Barron's. View real-time PACB stock price and news, along with industry-best analysis.

Pacific Biosciences of California, Inc. designs, develops, and manufactures sequencing systems to resolve genetically complex problems.Biotech stock Pacific Biosciences could return 50% in 12 months: TD Cowen. Pacific Biosciences of California Inc (NASDAQ: PACB) is trading meaningfully up on Friday after a TD Cowen analyst turned super bullish on the biotechnology company. Pacific Biosciences stock has upsi...

And the warming slowdown. To understand why the west has been so dry since the turn of the century, cast your eye further west—to the natural waxing and waning of Pacific Ocean winds. Strong trade winds have been forcing heat into ocean dep...Pacific Biosciences of California, Inc. (NASDAQ: PACB) is a premier life science technology company that is designing, developing and manufacturing advanced sequencing solutions to help scientists ...Nov 27, 2023 · Pacific Biosciences of California Non-GAAP EPS of -$0.35 beats by $0.02, revenue of $27.35M beats by $0.06M SA News Thu, Feb. 16 Pacific Biosciences of California Q4 2022 Earnings Preview Pacific Biosciences of California, Inc. beats earnings expectations. Reported EPS is $-0.26, expectations were $-0.3. Operator: Good afternoon, everyone, and welcome to the PacBio Third Quarter ...View the latest Pacific Biosciences of California Inc. (PACB) stock price, news, historical charts, analyst ratings and financial information from WSJ.

Pacific Biosciences of California Inc. PACB (U.S.: Nasdaq) Pacific Biosciences of California Inc. View All companies. REAL TIME 12:47 PM EST 11/30/23. $8.62 USD.

Let’s take a look at how Pacific Biosciences of California Inc’s stock performed this quarter. Earnings: $-0.28 per share, versus the consensus estimate of $-0.32 per share, according to AAII’s Stock Investor Pro, Refinitiv and I/B/E/S. Revenue: $39 million, versus $33 million in the same period one year ago.

Find real-time PACB - Pacific Biosciences of California Inc stock quotes, company profile, ... Pacific Biosciences of California Inc (NASDAQ:PACB) 8.89. Delayed Data. As of Dec 01The low in the last 52 weeks of Pacific Biosciences of California stock was 5.74. According to the current price, Pacific Biosciences of California is 155.92% away from the 52-week low.٢٧‏/٠١‏/٢٠٢٣ ... The common stock is listed on the Nasdaq Global Select Market under the symbol “PACB”. Based in Menlo Park, California, Pacific Biosciences ...Traveling by car offers a sense of freedom and adventure that is hard to replicate with other modes of transportation. The Pacific Coast Highway, also known as Highway 1, stretches for over 600 miles along the stunning coastline of Californ...Pacific Biosciences of California, Inc. : News, information and stories for Pacific Biosciences of California, Inc. | Nasdaq: PACB | Nasdaq e5.obVqkYPOfJNKrd0Co_B5cEDheThrH58M33b_WYEND74.y-ES3Pr9L_cB-O5L7oYeOAiCA1UAWNt8kke9KdZaes-U4i_J76wr1xDpiANov 14, 2023 · Pacific Biosciences of California Inc’s Stock Price as of Market Close As of November 14, 2023, 4:00 PM, CST, Pacific Biosciences of California Inc’s stock price was $7.22. Pacific Biosciences of California Inc is up 12.11% from its previous closing price of $6.44.

Nov 29, 2023 · See the latest Pacific Biosciences of California Inc stock price (PACB:XNAS), related news, valuation, dividends and more to help you make your investing decisions. Pacific Biosciences Of California. stock was originally listed at a price of $16.44 in Oct 27, 2010. If you had invested in Pacific Biosciences Of California stock at $16.44 , your return over the last 13 years would have been -47.99% , for an annualized return of -4.9% (not including any dividends or dividend reinvestments).Currently, the analyst consensus on Pacific Biosciences is a Hold with an average price target of $11.40. See Insiders’ Hot Stocks on TipRanks >> The company has a one-year high of $14.20 and a ...Pacific Biosciences of California Trading Up 4.7 %. Shares of PACB opened at $8.88 on Friday. The firm’s 50 day simple moving average is $7.76 and its 200 day simple moving average is $10.63.Jan-26-23 08:52AM. Pacific Biosciences of California (NASDAQ:PACB) shareholder returns have been massive, earning 313% in 5 years. (Simply Wall St.) Jan-24-23 …

9.38M. AMZN. 146.74. +0.02%. 21.61M. View today's Pacific Biosciences of California stock price and latest PACB news and analysis. Create real-time notifications to follow any changes in the live ...

STOCK INFORMATION IRS Notification. Form 8937 Omniome. Stock Quote ... Pacific Biosciences of California, Inc. 1305 O’Brien Drive, Menlo Park, CA 94025Pacific Biosciences of California has been profitable 1 over the past 10 years. Over the past twelve months, the company had a revenue of $146.10 million and Loss Per Share of $1.35.The notes will have a conversion price of $43.50 per share of the company's common stock, representing a 10% premium over Pacific Biosciences' share price as of the end of yesterday's trading session.Pacific Biosciences Of California Inc. (NASDAQ: PACB) is a biotechnology company. In the last three months, Pacific Biosciences Of California Inc. (NASDAQ: PACB) stock gained 182% and on February ...Pacific Biosciences of California, Inc. (Nasdaq: PACB) ("PacBio") today announced that it has priced its previously announced underwritten public offering of 17,500,000 shares of its common stock ...And the warming slowdown. To understand why the west has been so dry since the turn of the century, cast your eye further west—to the natural waxing and waning of Pacific Ocean winds. Strong trade winds have been forcing heat into ocean dep...Ulysses Erickson. December 4, 2023. Company. Pacific Biosciences of California Inc (NASDAQ:PACB) has a beta value of 1.83 and has seen 0.81 million shares traded in the recent trading session. The company, currently valued at $2.37B, closed the recent trade at $8.86 per share which meant it lost -$0.02 on the day or -0.17% during that session.Pacific Biosciences of California, Inc. is a life science technology company. The Company designs, develops and manufactures advanced sequencing solutions to help scientists and clinical researchers resolve genetically complex problems. ... Stock Pacific Biosciences of California, Inc. - Nasdaq . News Pacific Biosciences of …Pacific Biosciences of California Inc’s price is currently up 27.53% so far this month. During the month of March, Pacific Biosciences of California Inc’s stock price has reached a high of $11.79 and a low of $8.01. Over the last year, Pacific Biosciences of California Inc has hit prices as high as $14.20 and as low as $3.85.

Pacific Biosciences of California Inc is up 8.17% from its previous closing price of $7.22. During the last market session, Pacific Biosciences of California Inc’s stock traded between $7.00 and $7.43. Currently, there are 255.00 million shares of Pacific Biosciences of California Inc stock available for purchase.

Nov 24, 2023 · Get a real-time Pacific Biosciences of California, Inc. (PACB) stock price quote with breaking news, financials, statistics, charts and more.

PacBio Also Closes $300 Million PIPE Financing in Support of Transaction. MENLO PARK, Calif., Sept. 20, 2021 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq: PACB) (“Pacific Biosciences” or “PacBio”), a leading provider of high-quality, long-read sequencing platforms, and Omniome, a San Diego-based biotechnology ...Apr 11, 2023 · April 11, 2023 at 12:00 PM · 4 min read. Pacific Biosciences of California (PACB) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). An upward trend in ... Nov 28, 2023 · In other Pacific Biosciences of California news, insider Christian O. Henry sold 96,844 shares of the stock in a transaction dated Monday, September 18th. The stock was sold at an average price of $10.12, for a total value of $980,061.28. As of September 25, 2023, 4:00 PM, CST, Pacific Biosciences of California Inc’s stock price was $8.46. Pacific Biosciences of California Inc is down 5.37% from its previous closing price of $8.94. During the last market session, Pacific Biosciences of California Inc’s stock traded between $8.88 and $9.11.Pacific Biosciences of California Inc’s ( PACB) price is currently up 16.83% so far this month. During the month of November, Pacific Biosciences of California Inc’s stock price has reached a high of $7.45 and a low of $5.74. Over the last year, Pacific Biosciences of California Inc has hit prices as high as $14.55 and as low …MENLO PARK, Calif., April 29, 2021 (GLOBE NEWSWIRE) -- Pacific Biosciences of California, Inc. (NASDAQ: PACB) today announced financial results for the quarter ended March 31, 2021.UBS Group upgraded shares of Pacific Biosciences of California (NASDAQ:PACB – Free Report) from a neutral rating to a buy rating in a research note issued to investors on Friday, Marketbeat.com reports. They currently have $10.00 price target on the biotechnology company’s stock, down from their previous price target of …So what. Softbank subsidiary SB Management will purchase $900 million in convertible senior notes that it can convert into PacBio stock at a price of $43.50 per share. The notes mature on Feb. 15 ...١٢‏/١٠‏/٢٠٢٣ ... Shares of Pacific Biosciences of California (PACB) - Get Free Report, a life science technology company focused on solving genetic problems, ...

Jan 25, 2023 · 24 Jan, 2023, 23:18 ET. MENLO PARK, Calif., Jan. 24, 2023 /PRNewswire/ -- Pacific Biosciences of California, Inc. (Nasdaq: PACB) ("PacBio") today announced that it has priced its previously ... Discover historical prices for PACB stock on Yahoo Finance. View daily, weekly or monthly format back to when Pacific Biosciences of California, Inc. stock was issued. Home. Mail; News; Sports; ... Pacific Biosciences of California, Inc. (PACB) NasdaqGS - NasdaqGS Real Time Price. Currency in USD. Add to watchlist. 6.52 0.00 (0.00%)Pacific Biosciences Of California. stock was originally listed at a price of $16.44 in Oct 27, 2010. If you had invested in Pacific Biosciences Of California stock at $16.44, your return over the last 13 years would have been -47.99%, for an annualized return of -4.9% (not including any dividends or dividend reinvestments).Pacific Biosciences of California Stock Forecast 11-26-2023. Forecast target price for 11-26-2023: $ 8.02. Negative dynamics for Pacific Biosciences of California shares will prevail with possible volatility of 5.469%. Pessimistic target level: 7.80.Instagram:https://instagram. real estate investment appsnasdaq tndmbest bank with mobile appairr etf Pacific Biosciences of California Inc. published this content on 15 November 2022 and is solely responsible for the information contained therein. Distributed by Public , unedited and unaltered, on 15 November 2022 20:01:02 UTC . smin etfbest income annuity Nov 16, 2023 · Get the latest Pacific Biosciences of California Inc. (PACB) stock price, news, buy or sell recommendation, and investing advice from Wall Street professionals. organigram holding stock Aug 2, 2023 · Pacific Biosciences (PACB) delivered earnings and revenue surprises of 23.53% and 17.95%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock? The company's average rating score is 2.73, and is based on 8 buy ratings, 3 hold ratings, and no sell ratings. Price Target Upside/Downside. According to ...